References
- Akanbi, M. O., Iroz, C. B., O'Dwyer, L. C., Rivera, A. S., & McHugh, M. C. (2020). A systematic review of the effectiveness of employer-led interventions for drug misuse. Journal of Occupational Health, 62(1), e12133. https://doi.org/10.1002/1348-9585.12133
- Anderson, D. M., Rees, D. I., & Tekin, E. (2018). Medical marijuana laws and workplace fatalities in the United States. The International Journal on Drug Policy, 60, 33–39. https://doi.org/10.1016/j.drugpo.2018.07.008
- Asbridge, M., Valleriani, J., Kwok, J., & Erickson, P. G. (2016). Normalization and denormalization in different legal contexts: Comparing cannabis and tobacco. Drugs: Education, Prevention and Policy, 23(3), 212–223. https://doi.org/10.3109/09687637.2015.1118442
- Australian Bureau of Statistics. (2013). Australian and New Zealand Standard Industrial Classification (ANZSIC) 2006 (Revision 2.0) ABS. https://www.abs.gov.au/AUSSTATS/[email protected]/second+level+view?ReadForm&prodno=1292.0&viewtitle=Australian%20and%20New%20Zealand%20Standard%20Industrial%20Classification%20(ANZSIC)∼2006%20(Revision%202.0)∼Latest∼26/06/2013&&tabname=Past%20Future%20Issues&prodno=1292.0&issue=2006%20(Revision%202.0)&num=&view=&
- Australian Institute of Health and Welfare. (2011). National Drug Strategy Household Survey 2010: Confidentialised unit record file. Available from the Australian Data Archive.
- Australian Institute of Health and Welfare. (2014). National Drug Strategy Household Survey 2013: Confidentialised unit record file. Available from the Australian Data Archive.
- Australian Institute of Health and Welfare. (2017a). National Drug Strategy Household Survey 2016: Confidentialised unit record file. Available from the Australian Data Archive.
- Australian Institute of Health and Welfare. (2017b). National Drug Strategy Household Survey 2016: Detailed Findings. AIHW. https://www.aihw.gov.au/reports/illicit-use-of-drugs/national-drug-strategy-household-survey-2019/contents/summary
- Australian Institute of Health and Welfare. (2020a). National Drug Strategy Household Survey 2019. AIHW. https://www.aihw.gov.au/reports/illicit-use-of-drugs/national-drug-strategy-household-survey-2019
- Australian Institute of Health and Welfare. (2020b). National Drug Strategy Household Survey 2019: Online Data Tables. AIHW. https://www.aihw.gov.au/reports/illicit-use-of-drugs/national-drug-strategy-household-survey-2019/data
- Australian Institute of Health and Welfare. (2021). National Drug Strategy Household Survey 2019: Confidentialised unit record file.
- Bacchi, C. (2015). Problematizations in alcohol policy: WHO’s “alcohol problems”. Contemporary Drug Problems, 42(2), 130–147. https://doi.org/10.1177/0091450915576116
- Bernerth, J. B., & Walker, H. J. (2020). Altered states or much to do about nothing? A study of when cannabis is used in relation to the impact it has on performance. Group & Organization Management, 45(4), 459–478. https://doi.org/10.1177/1059601120917590
- Bonomo, Y., Norman, A., Biondo, S., Bruno, R., Daglish, M., Dawe, S., Egerton-Warburton, D., Karro, J., Kim, C., Lenton, S., Lubman, D. I., Pastor, A., Rundle, J., Ryan, J., Gordon, P., Sharry, P., Nutt, D., & Castle, D. (2019). The Australian drug harms ranking study. Journal of Psychopharmacology, 33(7), 759–768. https://doi.org/10.1177/0269881119841569
- Bowles, N. P., Herzig, M. X., & Shea, S. A. (2017). Recent legalization of cannabis use: effects on sleep, health, and workplace safety. Nature and Science of Sleep, 9, 249–251. https://doi.org/10.2147/NSS.S152231
- Brody, B. (2021). Amazon wants to legalize pot, but it’s defending drug tests in court. Protocol. https://www.protocol.com/workplace/amazon-weed-testing
- Bures, B. (2020). How the coronavirus pandemic is increasing global demand for marijuana. Chicago Tribune. https://www.chicagotribune.com/marijuana/sns-tft-coronavirus-increases-global-marijuana-demand-20200701-oygaxryb7vhcjfeu44cgacicaa-story.html
- Burgard, D. A., Williams, J., Westerman, D., Rushing, R., Carpenter, R., LaRock, A., Sadetsky, J., Clarke, J., Fryhle, H., Pellman, M., & Banta-Green, C. J. (2019). Using wastewater-based analysis to monitor the effects of legalized retail sales on cannabis consumption in Washington State, USA. Addiction, 114(9), 1582–1590. https://doi.org/10.1111/add.14641
- Carnide, N., Lee, H., Frone, M. R., Furlan, A. D., & Smith, P. M. (2021). Patterns and correlates of workplace and non-workplace cannabis use among Canadian workers before the legalization of non-medical cannabis. Drug and Alcohol Dependence, 218, 108386. https://doi.org/10.1016/j.drugalcdep.2020.108386
- Caulkins, J. P. (2021). Radical technological breakthroughs in drugs and drug markets: The cases of cannabis and fentanyl. The International Journal on Drug Policy, 94, 103162. https://doi.org/10.1016/j.drugpo.2021.103162
- Chapman, J., Roche, A. M., Duraisingam, V., Phillips, B., Finnane, J., & Pidd, K. (2021). Working at heights: Patterns and predictors of illicit drug use in construction workers. Drugs: Education, Prevention and Policy, 28(1), 67–75. https://doi.org/10.1080/09687637.2020.1743645
- CNBC (Producer). (2021). British American Tobacco to buy nearly 20% stake in Canada-based cannabis producer Organigram. https://www.cnbc.com/2021/03/11/british-american-tobacco-to-buy-stake-in-cannabis-producer-organigram.html
- Cook, L. (2021). NY employers can’t test for marijuana, with few exceptions. PIX 11. https://pix11.com/news/local-news/ny-employers-cant-test-for-marijuana-with-few-exceptions/
- Cooke, A., Chavez, L., & Freisthler, B. (2020). The relationships between chronic pain and changes in health with cannabis consumption patterns. International Journal on Drug Policy., 76, 102657. https://doi.org/10.1016/j.drugpo.2019.102657
- Ellis, W. E. J. (2016). High times: Impact of changing marijuana laws on the workplace https://www.hpylaw.com/publications/high-times-impact-of-changing-marijuana-laws-on-the-workplace/
- Glasser, N. M., Regne, A. A., Emanuelson, E. I. J., & Russell, J. D. (2021). Marijuana legalization rundown: new legislation across several states. Epstein Becker & Green, P.C.
- Gorfinkel, L., Stohl, M., Greenstein, E., Aharonovich, E., Olfson, M., & Hasin, D. (2021). Is Cannabis being used as a substitute for non-medical opioids by adults with problem substance use in the United States? Addiction (Abingdon, England), 116(5), 1113–1121. https://doi.org/10.1111/add.15228
- Hall, W., & Lynskey, M. (2005). Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs. Drug and Alcohol Review, 24(1), 39–48. https://doi.org/10.1080/09595230500126698
- Hall, W., & Lynskey, M. (2016). Evaluating the public health impacts of legalizing recreational cannabis use in the United States. Addiction, 111(10), 1764–1773. https://doi.org/10.1111/add.13428
- Hasin, D., Shmulewitz, D., & Sarvet, A. (2019). Time trends in US cannabis use and cannabis use disorders overall and by sociodemographic subgroups: A narrative review and new findings. The American Journal of Drug and Alcohol Abuse, 45(6), 623–643. https://doi.org/10.1080/00952990.2019.1569668
- Hsu, G., & Kovács, B. (2021). Association between county level cannabis dispensary counts and opioid related mortality rates in the United States: panel data study. BMJ, 372, m4957. https://doi.org/10.1136/bmj.m4957
- LaFrance, E. M., Glodosky, N. C., Bonn-Miller, M., & Cuttler, C. (2020). Short and long-term effects of cannabis on symptoms of post-traumatic stress disorder. Journal of Affective Disorders, 274, 298–304. https://doi.org/10.1016/j.jad.2020.05.132
- Lau, N., Sales, P., Averill, S., Murphy, F., Sato, S. O., & Murphy, S. (2015). A safer alternative: Cannabis substitution as harm reduction. Drug and Alcohol Review, 34(6), 654–659. https://doi.org/10.1111/dar.12275
- Leyton, M. (2019). Cannabis legalization: Did we make a mistake? Update 2019. Journal of Psychiatry & Neuroscience, 44(5), 291–293. https://doi.org/10.1503/jpn.190136
- Livingston, M., Raninen, J., Slade, T., Swift, W., Lloyd, B., & Dietze, P. (2016). Understanding trends in Australian alcohol consumption-an age-period-cohort model. Addiction, 111(9), 1590–1598. https://doi.org/10.1111/add.13396
- McEntee, A., Roche, A., & Whetton, S. (2020). Chapter 6: Workplace costs. In R. J. Tait, Allsop S. (Eds.). Quantifying the Social Costs of Cannabis Use to Australia in 2015/16. National Drug Research Institute, Curtin University.
- Morano, L. H., Steege, A. L., & Luckhaupt, S. E. (2018). Occupational patterns in unintentional and undetermined drug-involved and opioid-involved overdose deaths – United States, 2007-2012. MMWR. Morbidity and Mortality Weekly Report, 67(33), 925–930. https://www.medscape.com/viewarticle/901184. https://doi.org/10.15585/mmwr.mm6733a3
- Nagele-Piazza, L. (2020). Marijuana and the Workplace: What's New for 2020? Society for Human Resource Management (SHRM). https://www.shrm.org/resourcesandtools/legal-and-compliance/state-and-local-updates/pages/marijuana-and-the-workplace-new-for-2020.aspx
- The Parliament of the Commonwealth of Australia. (2016). Narcotic Drugs Amendment Bill 2016. Commonwealth of Australia, Canberra. https://parlinfo.aph.gov.au/parlInfo/search/display/display.w3p;query=Id:%22legislation/bills/r5609_aspassed/0000%22
- Ompad, D. C., Gershon, R. R., Sandh, S., Acosta, P., & Palamar, J. J. (2019). Construction trade and extraction workers: A population at high risk for drug use in the United States, 2005–2014. Drug and Alcohol Dependence, 205, 107640. https://doi.org/10.1016/j.drugalcdep.2019.107640
- Pacek, L. R., Weinberger, A. H., Zhu, J., & Goodwin, R. D. (2020). Rapid increase in the prevalence of cannabis use among people with depression in the United States, 2005-17: the role of differentially changing risk perceptions. Addiction, 115(5), 935–943. https://doi.org/10.1111/add.14883
- Pidd, K., & Roche, A. (2008). Changing workplace cultures: An integrated model for the prevention and treatment of alcohol-related problems. Drugs and public health: Australian perspectives on policy and practice (pp. 49–59).
- Pidd, K., & Roche, A. M. (2014). How effective is drug testing as a workplace safety strategy? A systematic review of the evidence. Accident; Analysis and Prevention, 71, 154–165. https://doi.org/10.1016/j.aap.2014.05.012
- Pidd, K., Kostadinov, V., & Roche, A. (2016). Do workplace policies work? An examination of the relationship between alcohol and other drug policies and workers' substance use. The International Journal on Drug Policy, 28, 48–54. https://doi.org/10.1016/j.drugpo.2015.08.017
- Pusiak, R. J. P., Cox, C., & Harris, C. S. (2021). Growing pains: An overview of cannabis quality control and quality assurance in Canada. The International Journal on Drug Policy, 93, 103111. https://doi.org/10.1016/j.drugpo.2021.103111
- Railton, D. (2018). Marijuana: Good or bad? Medical News Today. https://www.medicalnewstoday.com/articles/320984
- Roche, A., Kostadinov, V., Chapman, J., & McEntee, A. (2021). Have decreases in young workers’ risky drinking resulted in an increase in illicit drug use? Health Promotion Journal of Australia, 32(S2), 248–255. https://doi.org/10.1002/hpja.454
- Sagar-Ouriaghli, I., Godfrey, E., Bridge, L., Meade, L., & Brown, J. S. L. (2019). Improving mental health service utilization among men: A systematic review and synthesis of behavior change techniques within interventions targeting help-seeking. American Journal of Men's Health, 13(3), 1557988319857009. https://doi.org/10.1177/1557988319857009
- Sanchez, V. (2021). Is cannabis use the same as off-duty drinking by workers? Many companies still say no. At Work. https://www.cnbc.com/2019/07/27/will-cannabis-use-soon-be-the-same-as-off-duty-drinking-by-workers.html
- Sarvet, A., Wall, M., Fink, D., Greene, E., Le, A., Boustead, A., Pacula, R., Keyes, K., Cerdá, M., Galea, S., & Hasin, D. (2018). Medical marijuana laws and adolescent marijuana use in the United States: A systematic review and meta-analysis. Addiction, 113(6), 1003–1016. https://doi.org/10.1111/add.14136
- Schlag, A. K., Hindocha, C., Zafar, R., Nutt, D. J., & Curran, H. V. (2021). Cannabis based medicines and cannabis dependence: A critical review of issues and evidence. Journal of Psychopharmacology, 35(7), 773–785. https://doi.org/10.1177/0269881120986393
- Shaw, M. (2021). The world seems ripe for policy change-but how to achieve it? The International Journal on Drug Policy, 89, 103188. https://doi.org/10.1016/j.drugpo.2021.103188
- Stoner, S. (2017). Effects of Marijuana on Mental Health: Anxiety Disorders (http://adai.uw.edu/pubs/pdf/2017mjanxiety.pdf
- Strickland, J. R., Wagan, S., Dale, A. M., & Evanoff, B. A. (2017). Prevalence and perception of risky health behaviors among construction workers. Journal of Occupational and Environmental Medicine, 59(7), 673–678. https://doi.org/10.1097/JOM.0000000000001051
- United Nations: Office on Drugs and Crime. (2019). World Drug Report 2019: 35 million people worldwide suffer from drug use disorders while only 1 in 7 people receive treatment.
- United Nations: Office on Drugs and Crime. (2021). UNODC World Drug Report 2021: pandemic effects ramp up drug risks, as youth underestimate cannabis dangers.
- van Laar, M. W., Oomen, P. E., van Miltenburg, C. J. A., Vercoulen, E., Freeman, T. P., & Hall, W. D. (2020). Cannabis and COVID-19: reasons for concern [Brief Research Report]. Frontiers in Psychiatry, 11, 601419–601653. https://doi.org/10.3389/fpsyt.2020.601653
- Whetton, S., Tait, R. J., Chrzanowska, A., Donnelly, N., McEntee, A., Mukhtar, A., Zahra, E., Campbell, G., Degenhardt, L., Dey, T., Abdul Halim, S., Hall, W., Makate, M., Norman, R., Peacock, A., Roche, A., & Allsop, S. (2020). Quantifying the Social Costs of Cannabis Use to Australia in 2015/16 (https://ndri.curtin.edu.au/ndri/media/documents/publications/T287.pdf
- White, S., McCaffrey, N., & Scollo, M. (2020). Tobacco dependence treatment in Australia – an untapped opportunity for reducing the smoking burden. Public Health Research & Practice, 30(3), e3032020. https://doi.org/10.17061/phrp3032020
- Wilkins, C., & Rychert, M. (2021). Assessing New Zealand's Cannabis legalization and control bill: Prospects and challenges. Addiction, 116(2), 222–230. https://doi.org/10.1111/add.15144
- Winstock, A. R., Lynskey, M. T., Maier, L. J., Ferris, J. A., & Davies, E. L. (2021). Perceptions of cannabis health information labels among people who use cannabis in the U.S. and Canada. The International Journal on Drug Policy, 91, 102789. https://doi.org/10.1016/j.drugpo.2020.102789
- Yang, K. H., Kaufmann, C. N., Nafsu, R., Lifset, E. T., Nguyen, K., Sexton, M., Han, B. H., Kim, A., & Moore, A. A. (2021). Cannabis: An emerging treatment for common symptoms in older adults. Journal of the American Geriatrics Society, 69(1), 91–97. https://doi.org/10.1111/jgs.16833
- Zhang, J. C., Carnide, N., Holness, L., & Cram, P. (2020). Cannabis use and work-related injuries: A cross-sectional analysis. Occupational Medicine, 70(8), 570–577. https://doi.org/10.1093/occmed/kqaa175
- Zvonarev, V., Fatuki, T. A., & Tregubenko, P. (2019). The public health concerns of marijuana legalization: An overview of current trends. Cureus, 11(9), e5806. https://doi.org/10.7759/cureus.5806
- Zwerling, C., Ryan, J., & Orav, E. J. (1990). The efficacy of preemployment drug screening for marijuana and cocaine in predicting employment outcome. JAMA, 264(20), 2639–2643. https://doi.org/10.1001/jama.1990.03450200047029